DCCR was approved by the U.S. Food and Drug Administration (FDA) under the brand name VYKAT™ XR on March 26, 2025. Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by ...

In a comprehensive Genomic Press Invited Expert Review, researchers from the University of Haifa have synthesized cutting-edge findings on Prader-Willi syndrome (PWS), revealing how this complex ...

HAIFA, Israel, 20 May 2025 – In a comprehensive Genomic Press Invited Expert Review, researchers from the University of Haifa have synthesized cutting-edge findings on Prader-Willi syndrome (PWS ...

Batesburg residents are coming together for a cause that touches lives in a very personal way. On May 22nd, the Babcock Center will host the annual Prader-Willi Walk ...

In a comprehensive Genomic Press Invited Expert Review, researchers from the University of Haifa have synthesized ...

The data concerns its product VYKAT XR, an extended-release tablet designed to treat hyperphagia in individuals with Prader-Willi syndrome (PWS). The study findings indicated that patients with ...

PWS is a rare genetic disorder characterized by insatiable hunger, leading to dangerous food-seeking behaviors and severe ...

Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

Katie Price has had another swipe at ex-partner and dad to son Harvey, Dwight Yorke, after saying he left her to 'fend for ...

A 5-year-old girl from Bangladesh suffering from Prader-Willi Syndrome, a rare genetic condition leading to extreme childhood obesity, underwent bariatric surgery at a private hospital in Chennai.